Your browser doesn't support javascript.
loading
Intracranial Aneurysm Classifier Using Phenotypic Factors: An International Pooled Analysis.
Morel, Sandrine; Hostettler, Isabel C; Spinner, Georg R; Bourcier, Romain; Pera, Joanna; Meling, Torstein R; Alg, Varinder S; Houlden, Henry; Bakker, Mark K; Van't Hof, Femke; Rinkel, Gabriel J E; Foroud, Tatiana; Lai, Dongbing; Moomaw, Charles J; Worrall, Bradford B; Caroff, Jildaz; Constant-Dits-Beaufils, Pacôme; Karakachoff, Matilde; Rimbert, Antoine; Rouchaud, Aymeric; Gaal-Paavola, Emilia I; Kaukovalta, Hanna; Kivisaari, Riku; Laakso, Aki; Jahromi, Behnam Rezai; Tulamo, Riikka; Friedrich, Christoph M; Dauvillier, Jerome; Hirsch, Sven; Isidor, Nathalie; Kulcsàr, Zolt; Lövblad, Karl O; Martin, Olivier; Machi, Paolo; Mendes Pereira, Vitor; Rüfenacht, Daniel; Schaller, Karl; Schilling, Sabine; Slowik, Agnieszka; Jaaskelainen, Juha E; von Und Zu Fraunberg, Mikael; Jiménez-Conde, Jordi; Cuadrado-Godia, Elisa; Soriano-Tárraga, Carolina; Millwood, Iona Y; Walters, Robin G; Kim, Helen; Redon, Richard; Ko, Nerissa U; Rouleau, Guy A.
Afiliação
  • Morel S; Neurosurgery Division, Department of Clinical Neurosciences, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Hostettler IC; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.
  • Spinner GR; Stroke Research Centre, University College London Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Bourcier R; Department of Neurosurgery, Canton Hospital St. Gallen, 9000 St. Gallen, Switzerland.
  • Pera J; ZHAW School of Life Sciences and Facility Management, 8820 Wädenswil, Switzerland.
  • Meling TR; Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), University Hospital Centre Nantes, University of Nantes, L'institut Du Thorax, 44007 Nantes, France.
  • Alg VS; Department of Neuroradiology, University Hospital of Nantes, 44000 Nantes, France.
  • Houlden H; Department of Neurology, Faculty of Medicine, Jagiellonian University Medical College, ul. Botaniczna 3, 31-503 Krakow, Poland.
  • Bakker MK; Neurosurgery Division, Department of Clinical Neurosciences, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Van't Hof F; Stroke Research Centre, University College London Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Rinkel GJE; Neurogenetics Laboratory, The National Hospital of Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Foroud T; Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, 3584 CS Utrecht, The Netherlands.
  • Lai D; Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, 3584 CS Utrecht, The Netherlands.
  • Moomaw CJ; Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, 3584 CS Utrecht, The Netherlands.
  • Worrall BB; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Caroff J; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Constant-Dits-Beaufils P; Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Karakachoff M; Departments of Neurology and Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
  • Rimbert A; Department of Interventional Neuroradiology-NEURI Brain Vascular Center, Bicêtre Hospital, APHP, 94270 Le Kremlin Bicêtre, France.
  • Rouchaud A; Institut national de la santé et de la recherche médicale (INSERM), CIC 1413, Clinique des Données, University Hospital Centre Nantes, 44000 Nantes, France.
  • Gaal-Paavola EI; Institut national de la santé et de la recherche médicale (INSERM), CIC 1413, Clinique des Données, University Hospital Centre Nantes, 44000 Nantes, France.
  • Kaukovalta H; Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), University Hospital Centre Nantes, University of Nantes, L'institut Du Thorax, 44007 Nantes, France.
  • Kivisaari R; Department of Neuroradiology, Dupuytren University Hospital, 87000 Limoges, France.
  • Laakso A; Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, 00260 Helsinki, Finland.
  • Jahromi BR; Clinical Neurosciences, University of Helsinki, Topeliuksenkatu 5, 00260 Helsinki, Finland.
  • Tulamo R; Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, 00260 Helsinki, Finland.
  • Friedrich CM; Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, 00260 Helsinki, Finland.
  • Dauvillier J; Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, 00260 Helsinki, Finland.
  • Hirsch S; Neurosurgery Research Group, Biomedicum, 00290 Helsinki, Finland.
  • Isidor N; Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, 00260 Helsinki, Finland.
  • Kulcsàr Z; Neurosurgery Research Group, Biomedicum, 00290 Helsinki, Finland.
  • Lövblad KO; Neurosurgery Research Group, Biomedicum, 00290 Helsinki, Finland.
  • Martin O; Department of Vascular Surgery, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
  • Machi P; Department of Computer Science, University of Applied Science and Arts, 44139 Dortmund, Germany.
  • Mendes Pereira V; Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, 45147 Essen, Germany.
  • Rüfenacht D; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Schaller K; ZHAW School of Life Sciences and Facility Management, 8820 Wädenswil, Switzerland.
  • Schilling S; Neurosurgery Division, Department of Clinical Neurosciences, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Slowik A; Diagnostic and Interventional, Department of Diagnostics, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Jaaskelainen JE; Diagnostic and Interventional, Department of Diagnostics, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • von Und Zu Fraunberg M; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Jiménez-Conde J; Diagnostic and Interventional, Department of Diagnostics, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Cuadrado-Godia E; Division of Neurosurgery, Department of Surgery, St Michael's Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada.
  • Soriano-Tárraga C; Swiss Neuroradiology Institute, 8002 Zurich, Switzerland.
  • Millwood IY; Neurosurgery Division, Department of Clinical Neurosciences, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Walters RG; ZHAW School of Life Sciences and Facility Management, 8820 Wädenswil, Switzerland.
  • The neurIST Project; Lucerne School of Business, Lucerne University of Applied Sciences, 6002 Lucerne, Switzerland.
  • The Ican Study Group; Department of Neurology, Faculty of Medicine, Jagiellonian University Medical College, ul. Botaniczna 3, 31-503 Krakow, Poland.
  • Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators; Neurosurgery NeuroCenter Kuopio, University Hospital Kuopio, 70210 Kuopio, Finland.
  • International Stroke Genetics Consortium Isgc; Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland.
J Pers Med ; 12(9)2022 Aug 30.
Article em En | MEDLINE | ID: mdl-36143196
Intracranial aneurysms (IAs) are usually asymptomatic with a low risk of rupture, but consequences of aneurysmal subarachnoid hemorrhage (aSAH) are severe. Identifying IAs at risk of rupture has important clinical and socio-economic consequences. The goal of this study was to assess the effect of patient and IA characteristics on the likelihood of IA being diagnosed incidentally versus ruptured. Patients were recruited at 21 international centers. Seven phenotypic patient characteristics and three IA characteristics were recorded. The analyzed cohort included 7992 patients. Multivariate analysis demonstrated that: (1) IA location is the strongest factor associated with IA rupture status at diagnosis; (2) Risk factor awareness (hypertension, smoking) increases the likelihood of being diagnosed with unruptured IA; (3) Patients with ruptured IAs in high-risk locations tend to be older, and their IAs are smaller; (4) Smokers with ruptured IAs tend to be younger, and their IAs are larger; (5) Female patients with ruptured IAs tend to be older, and their IAs are smaller; (6) IA size and age at rupture correlate. The assessment of associations regarding patient and IA characteristics with IA rupture allows us to refine IA disease models and provide data to develop risk instruments for clinicians to support personalized decision-making.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article